Skip to main content

AMIA 2020 Informatics Summit Keynote Speakers

Opening Keynote Speaker

Monday, March 23, 11:00 a.m. – 12:00 p.m. EDT

atul-butte-cropped.jpg

Atul Butte, MD, PhD, is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Institute (bchsi.ucsf.edu) at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire University of California Health System, with 18 health professional schools, six medical centers, 10 hospitals, and more than 1,000 care delivery sites.  Dr. Butte has been continually funded by NIH for 20 years, is an inventor on 24 patents, and has authored more than 200 publications, with research repeatedly featured in the New York Times, Wall Street Journal, and Wired Magazine. Dr. Butte was elected into the National Academy of Medicine in 2015, and in 2013, he was recognized by the Obama Administration as a White House Champion of Change in Open Science for promoting science through publicly available data. Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis (IPO, 2019), providing medical genome sequencing services, Carmenta (acquired by Progenity, 2015), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, then received his PhD from Harvard Medical School and MIT.

Voices of AMIA: A Listening Session for Strategic Planning

Tuesday, March 24, 11:00 a.m. – 12:00 p.m. EDT

Dykes-Patti-074_pp-square-PREFFERRED (1).jpg

Join AMIA Board Chair, Patti Dykes, along with AMIA Board members, at the Voices of AMIA Listening Session for Strategic Planning.

As AMIA continues our strategic visioning process for the 2020-2025 strategic plan, we want to hear from you, the AMIA audience, about your goals and vision for AMIA in the next 5-10 years. We are seeking way to improve AMIA and the value it offers to members.

Here are a few of the topics we will be discussing:

  • We want to hear about your most exceptional, effective, inspiring experiences with AMIA – and about how we can generate many more of those experiences for each of you.
  • In the 5 to 10-year future, what’s in store for the informatics field? How can AMIA shape this future, and help each of our members to shape it?

Translational Bioinformatics and Data Science Year in Review

Tuesday, March 24, 11:00 a.m. – 12:00 p.m. EDT

In addition to presenting the best and brightest of 2019’s published translational bioinformatics papers, Dr. Tatonetti will be reviewing the published research on the current pandemic, COVID-19. The presentation will focus on coronavirus papers that will be of greatest interest to the informatics community, i.e. data-driven, methods-oriented, and/or modeling-based.

NicholasTatonetti.jpg

Nicholas Tatonetti, PhD
Associate Professor, Biomedical Informatics, Columbia University; Director of Clinical Informatics, Institute for Genomic Medicine, Columbia University

Dr. Nicholas Tatonetti is associate professor of biomedical informatics in the departments of Biomedical Informatics, Systems Biology, and Medicine and is Director of Clinical Informatics at the Institute for Genomic Medicine at Columbia University. He received his PhD from Stanford University where he focused on the development of novel statistical and computational methods for observational data mining. He applied these methods to drug safety surveillance and the discovery of dangerous drug-drug interactions. His lab at Columbia is focused on expanding upon his previous work in detecting, explaining, and validating drug effects and drug interactions from large-scale observational data. Widely published in both clinical and bioinformatics, Dr. Tatonetti is passionate about the integration of hospital data (stored in the electronic health records) and high-dimensional biological data (captured using next-generation sequencing, high-throughput screening, and other "omics" technologies). Dr. Tatonetti has been featured by the New York Times, Genome Web, and Science Careers. His work has been picked up by the mainstream and scientific media and generated thousands of news articles.

Closing Keynote Speaker

Thursday, March 26, 4:15 p.m. – 5:15 p.m. EDT

Janina.jpg

Janina M. Jeff, PhD, is a Senior Bioinformatics Scientist at Illumina, where she develops pipelines for content annotation and the selection and design of population specific genome-wide content for Illumina’s genotyping array portfolios to enable healthy population screening. She is the first African American to graduate with a PhD in Human Genetics from Vanderbilt University. Before Illumina, her research career was largely focused on the discovery of genetic loci that impact admixed populations, Hispanics and African Americans, for complex common diseases. In the past year, Dr. Jeff was named Top 40 Under 40 Alumna with Spelman College, The National Quality Minority Forum, and The Network Journal. She also recently gave her first TEDx talk at the inaugural TEDxFlatbush, “Afrofuturism Through the Power of the Genome” and was recently featured by The Root One-word project during Black History Month on genetic testing.